The FDA approved a label update for 2 versions of the Depo-Provera birth control injection to include the risk for meningioma.

Pfizer faces a lawsuit in which women allege the drugmaker failed to warn them about the risks of meningioma associated with the birth control shot.

With thousands of lawsuits and growing concerns over long-term risks, the FDA have added brain tumor warning to the label.

FDA adds brain tumor warning to Depo-Provera label for Pfizer’s birth control injections after studies link the drug to meningioma risk.

While there are many forms of birth control that use progestin, "no increased meningioma risk has been found with combined ...

The FDA approved a label update Friday for Pfizer's Depo-Provera birth control shot warning of meningioma—a brain tumor in ...

The FDA has approved a change to the labeling for a Pfizer birth control shot that warns patients of the risk of meningioma, ...

At a Friday hearing, U.S. District Judge M. Casey Rodgers, of the Northern District of Florida, ordered supplemental briefs ...

The pharma giant announced that the Food and Drug Administration approved its new safety warning label for Depo-Provera — Pfizer’s birth control injection that has been a subject of controversy as ...

WESTWEGO, Louisiana — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For ...